Matthew Lynde Named Intellectual Property Trailblazer by National Law Journal
Dr. Lynde received the honor for his lifetime achievements in applying advanced economic analysis to IP and patent damages.
2017 Who’s Who Legal
Cornerstone Research staff and affiliated experts were selected for the 2017 list of global leaders in competition and legal investigations.
The Future of the Markets Regime
This Cornerstone Research event in London featured competition and markets expert Rachel Merelie.
A Brave New World: What’s in Store?
Cornerstone Research hosted Stanford professor Joseph Grundfest to discuss current developments in securities regulation and litigation.
Los Angeles Women’s Forum 2017: Investing in Women and Gender Equity
Cornerstone Research hosted a networking event with Professor Kellie McElhaney of the Haas School of Business, University of California, Berkeley.
Estimating Damages in Litigation—Beyond Discounted Cash Flow
Ronnie Barnes spoke at a Cornerstone Research-sponsored interactive panel discussion in London.
SEC’s Renewed Focus On Non-GAAP Measures: 1 Year Later
In recent years, the use of non-GAAP financial measures has become more widespread.
Testifying Experts Draw Lessons from Recent Healthcare Mergers
This Cornerstone Research expert forum featured several healthcare merger experts.
Product Hopping
Pharmaceutical manufacturers have been accused of engaging in product hopping by introducing modified versions of branded drugs nearing patent expiry while simultaneously withdrawing the older drugs to hinder generic substitution.
Sampling in FCA Litigation
Clients draw on Cornerstone Research's statistical expertise to evaluate sampling analyses performed by opposing parties to prove liability and damages in False Claims Act litigation.
2017 Antitrust Writing Awards
John Asker of the University of California, Los Angeles was chosen as a winner in Concurrences Review’s annual selection of leading articles.
Approved Claims Rates in Securities Class Actions
When applied to aggregate damages estimates, approved claims rates from two recent securities case verdicts can provide an indication of potential damages exposure.
How can we help you?
If you are looking for a publication not on our website, contact us.